Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.532
+0.054 (11.21%)
At close: Feb 27, 2026, 4:00 PM EST
0.530
-0.002 (-0.30%)
After-hours: Feb 27, 2026, 7:54 PM EST
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $39.09 million as of February 27, 2026. Its market cap has increased by 322.95% in one year.
Market Cap
39.09M
Enterprise Value
31.74M
1-Year Change
322.95%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $39.09M, a decrease of -69.30%. That is a compound annual growth rate of -26.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 39.09M | 86.48% |
| Dec 31, 2025 | 20.96M | 103.27% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lite Strategy | 41.09M |
| Rallybio | 39.81M |
| Atara Biotherapeutics | 39.08M |
| Xilio Therapeutics | 38.81M |
| Jasper Therapeutics | 38.62M |
| Sensei Biotherapeutics | 38.60M |
| Atossa Therapeutics | 38.15M |
| NovaBay Pharmaceuticals | 37.62M |